Screening Coronary Arteriography in the Primary Prevention of Coronary Artery Disease

Heart Disease

Volumn 5, Issue 5, 2003, Pages 335-344

  Gandelman, Glenn ^a   Bodenheimer, Monty M ^b,c  

^a WESTCHESTER MEDICAL CENTER   (United States)

^b LONG ISLAND JEWISH MEDICAL CENTER   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Asymptomatic; Cholesterol; Coronary arteriography; Primary prevention; Statin

Indexed keywords

ANTILIPEMIC AGENT; STATINE;

ADULT; AGED; ANGIOCARDIOGRAPHY; ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; COST BENEFIT ANALYSIS; HUMAN; INTRAVASCULAR ULTRASOUND; MALE; PREVALENCE; PRIMARY PREVENTION; PROGNOSIS; REVIEW; SCREENING TEST;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; CORONARY ANGIOGRAPHY; CORONARY ARTERIOSCLEROSIS; COST-BENEFIT ANALYSIS; FEMALE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PREVALENCE; REPRODUCIBILITY OF RESULTS;

EID: 0142040202     PISSN: 1521737X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.hdx.0000080717.15994.64     Document Type: Review

References (76)

1. Sones FM Jr. Indications and value of coronary arteriography. Circulation. 1972;46:1155-1160.
2. Jacobson TA, Griffith GG, Varas C, Gause D, Sung JCY, Ballantyne CM. Impact of evidence-based "clinical judgment" on the number of American adults requiring lipid-lowering therapy based on updated NHANES III Data. National Health and Nutrition Examination Survey. Arch Intern Med. 2000;160:1361-1369.
3. LaRosa JC, He J, Vupputuri S. Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials. JAMA. 1999;282:2340-2346.
4. Pignone M, Phillips C, Mulrow C. Use of lipid lowering drugs for primary prevention of coronary heart disease: meta-analysis of randomized trials. BMJ. 2000;321:983-986.
5. Kumana CR, Cheung BM, Lauder IJ. Gauging the impact of statins using number needed to treat. JAMA. 1999;282:1899-1901.
6. Gotto AM Jr. Lipid management in patients at moderate risk for coronary heart disease:insights from the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). Am J Med. 1999;107(2A):36S-39S.
7. Gotto AM Jr, Ehitney E, Stein EA, et al. Application of the National Cholesterol education Program and joint European treatment criteria and clinical benefit in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). Eur Heart J. 2000;21:1627-1633.
8. Downs JR, Clearfield M, Weis S, et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels:results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. JAMA. 1998;279:1615-1622.
9. Shepherd J, Bobbe SM, Ford I, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med. 1995;333:1301-1307.
10. Gibbons RJ, Chaterjee K, Daley J, et al. ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina:executive summary and recommendations. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Chronic Stable Angina). Circulation. 1999;99:2829-2848.
11. Pitt B, Rubenfire M. Risk stratification for the detection of preclinical coronary artery disease. Circulation. 1999;99:2610-2612.
12. Shaw LJ, O'Rourke RA. The challenge of improving risk assessment in asymptomatic individuals:the additive prognostic value of electron beam tomography? J Am Coll Cardiol. 2000;36:1261-1264.
13. Hoff JA, Chomka EV, Krainik AJ, Daviglus M, Rich S, Kondos GT. Age and gender distributions of coronary artery disease detected by electron beam tomography in 35,246 adults. Am J Cardiol. 2001;87:1335-1339.
14. Smith Jr SC, Greenland P, Grundy SM. AHA Conference Proceedings. Prevention conference V. Beyond secondary prevention:identifying the high-risk patient for primary prevention. Executive summary. American Heart Association. Circulation. 2000;101:111-116.
15. Scanlon PJ, Faxon DP, Audet AM, et al. ACC/AHA guidelines for coronary angiography:executive summary and recommendations. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Coronary Angiography) developed in collaboration with the Society for Cardiac Angiography and Interventions. Circulation. 1999;99:2345-2357.
16. Diamond GA, Forrester JS. Analysis of probability as an aid in the clinical diagnosis of coronary-artery disease. N Engl J Med. 1979;300:1350-1358.
17. Enos WF, Holmes RH, Beyer J. Landmark article, July 18, 1953: Coronary disease among United States soldiers killed in action in Korea. Preliminary report. JAMA. 1986;256:2859-2862.
18. Davies MJ. Anatomic features in victims of sudden death. Coronary artery pathology. Circulation. 1992.;85(suppl 1):I19-I24.
19. Strong JP, Malcom GT, McMahan CA, Tracy RE, Newman WP III, Herderick, et al. Prevalence and extent of atherosclerosis in adolescents and young adults. JAMA. 1999;281:727-735.
20. Berenson GS, Srinivasan SR, Bao W, Newman WP III, Tracy RE, Wattigney WA. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N Engl J Med. 1998;338:1650-1656.
21. Chaitman BR, Bourassa MG, Davis K, et al. Angiographic prevalence of high-risk coronary artery disease in patient subsets (CASS). Circulation. 1981;64:360-367.
22. DeFilippi CR, Rosanio S, Tocchi M, et al. Randomized comparison of a strategy of predischarge coronary angiography versus exercise testing in low-risk patients in a chest pain unit:in-hospital and long-term outcomes. J Am Coll Cardiol. 2001;37:2042-2049.
23. Gensini GG, Kelly AE. Incidence and progression of coronary artery disease. An angiographic correlation in 1, 263 patients. Arch Intern Med. 1972;129:814-823.
24. Leung DY, Dawson IG, Thomas JD, Marwick TH. Accuracy and cost-effectiveness of exercise echocardiography for detection of coronary artery disease in patients with mitral valve prolapse. Am Heart J. 1997;134:1052-1057.
25. Enbergs A, Burger R, Reinecke H, Borggrefe M, Breithardt G, Kerber S. Prevalence of coronary artery disease in a general population without suspicion of coronary artery disease:angiographic analysis of subjects aged 40 to 70 years referred for catheter ablation therapy. Eur Heart J. 2000;21:45-52.
26. Carey WD, Dumont JA, Pimentel RR, et al. The prevalence of coronary artery disease in liver transplant candidates over age 50. Transplantation. 1995;59:859-864.
27. Thurnheer R, Muntwyler J, Stammberger U, et al. Coronary artery disease in patients undergoing lung volume reduction surgery for emphysema. Chest. 1997;112:122-128.
28. Arnett EN, Isner JM, Redwood DR, et al. Coronary artery narrowing in coronary heard disease:comparison of cineangiographic and necropsy findings. Ann Intern Med. 1979;91:350-356.
29. Kemp HG Jr, Evans H, Elliott WC, Gorlin R. Diagnostic accuracy of selective coronary cinearteriography. Circulation. 1967;36:526-533.
30. Vlodaver Z, Frech R, Van Tassel RA, Edwards JE. Correlation of antemortem coronary arteriogram and the postmortem specimen. Circulation. 1973;47:162-169.
31. Grondin CM, Dyrda I, Pasternac A, Campeau L, Bourassa MG, Lesperance J. Discrepancies between cineangiographic and postmortem findings in patients with coronary artery disease and recent myocardial revascularization. Circulation. 1974;49:703-708.
32. Hutchins GM, Bulkley BH, Ridolfi RL, Griffith LS, Lohr FT, Piasio MA. Correlation of coronary arteriograms and left ventriculograms with postmortem studies. Circulation. 1977;56:32-37.
33. Johnson MR. A normal coronary artery size is it?Circulation. 1992;86:331-333.
34. Glagov S, Weisenberg E, Zarins CK, Stankunavicius R, Kolettis GJ. Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med. 1987;316:1371-1375.
35. St. Goar FG, Pinto FJ, Alderman EL, et al. Detection of coronary atherosclerosis in young adult hearts using intravascular ultrasound. Circulation. 1992;86:756-763.
36. Ge J, Erbel R, Gerber T, et al. Intravascular ultrasound imaging of angiographically normal coronary arteries:a prospective study in vivo. Br Heart J. 1994;71:572-578.
37. Erbel R, Ge J, Gorge G, et al. Intravascular ultrasound classification of atherosclerotic lesions according to American Heart Association recommendation. Coron Artery Dis. 1999;10:489-499.
38. Nissen SE, Yock P. Intravascular ultrasound:Novel pathophysiological insights and current clinical applications. Circulation. 2001;103:604-616.
39. Bruschke AV, Proudfit WL, Sones FM. Clinical course of patients with normal and slightly or moderately abnormal coronary arteriograms:a follow-up study on 500 patients. Circulation. 1973;47:936-945.
40. Proudfit WL, Bruschke AVG, Sones FM. Clinical course of patients with normal or slightly or moderately abnormal coronary arteriograms:10-year follow-up of 521 patients. Circulation. 1980;62:712-717.
41. Proudfit WL, Welch CC, Siqueira C, Morcerf FP, Sheldon WC. Prognosis of 1000 young women studied by coronary angiography. Circulation. 1981;64:1185-1190.
42. Kemp HG Jr., Kronmal RA, Vlietstra RE, Frye RL. Seven year survival of patients with normal or near normal coronary arteriograms:a CASS registry study. J Am Coll Cardiol. 1986;7:479-483.
43. Papanicolaou MN, Califf RM, Hlatky MA, et al. Prognostic implications of angiographically normal and insignificantly narrowed coronary arteries. Am J Cardiol. 1986;58:1181-1187.
44. Lichtlen PR, Bargheer KB, WenzlaffP. Long-term prognosis of patients with angina-like chest pain and normal coronary findings. J Am Coll Cardiol. 1995;25:1013-1018.
45. Dawber TR. The Framingham Study. The Epidemiology of Atherosclerotic Disease. Cambridge: Harvard University Press; 1980:73,133-135.
46. Gensini GG, Esente P, Kelly A. Natural history of coronary disease in patients with and without coronary bypass graft surgery. Circulation. 1974;50(suppl 2):II98-II102.
47. Bruschke AV, Wijers TS, Kolsters W, Landman J. The anatomic evolution of coronary artery disease demonstrated by arteriography in 256 nonoperated patients. Circulation. 1981;63:527-536.
48. Kimbiris D, Lavine P, Van Den Broek H, Najmi M, Likoff W. Devolutionary pattern of coronary atherosclerosis in patients with angina pectoris. Coronary arteriographic studies. Am J Cardiol. 1974;33:7-10.
49. Rosch J, Antaonovic R, Trenouth RS, Rahimtoola SH, Sim DN, Dotter CT. The natural history of coronary artery stenosis. A longitudinal angiographic assessment. Radiology. 1976;119:513-520.
50. Marchandise B, Bourassa MG, Chaitman BR, Lesperance J. Angiographic evaluation of the natural history of normal coronary arteries and mild coronary atherosclerosis. Circulation. 1978;41:216-220.
51. Cox I, Schwartzman RA, Atienza F, Brown SJ, Kaski JC. Angiographic progression in patients with angina pectoris and normal or near normal coronary angiograms who are restudied due to unstable symptoms. Eur Heart J. 1998;19:1027-1033.
52. Jacobellis v Ohio. 378US 184(1964) USSC.
53. Little WC, Constantinescu M, Applegate RJ, et al. Can coronary angiography predict the site of a subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease? Circulation. 1988;78:736-745.
54. Ambrose JA, Tannenbaum MA, Alexopoulos D, et al. Angiographic progression of coronary artery disease and the development of myocardial infarction. J Am Coll Cardiol. 1988;12:56-62.
55. Davis K, Kennedy JW, Kemp HG Jr, Judkins MP, Gosselin AJ, Killip T. Complications of coronary arteriography from the collaborative study of coronary surgery (CASS). Circulation. 1979;59:1105-1112.
56. Kennedy JW. Complications associated with cardiac catheterization and angiography. Cathet Cardiovasc Diagn. 1982;8:5-11.
57. Johnson LW, Lozner EC, Johnson S, et al. Coronary arteriography 1984-1987:a report of the Registry of the Society for Cardiac Angiography and Interventions. Cathet Cardiovasc Diagn. 1989;17:5-10.
58. Sonnenberg A, Delco F, Inadomi JM. Cost-effectiveness of colonoscopy in screening for colorectal cancer. Ann Intern Med. 2000;133:573-584.
59. Lewis JD. Prevention and treatment of colorectal cancer:Pay now or pay later. Ann Intern Med. 2000;133:647-649.
60. Winawer SJ, Fletcher RH, Miller L, et al. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology. 1997;122:594-642.
61. Neaton JD, Blackburn H, Jacobs D, et al. Serum cholesterol level and mortality findings for men screened in the Multiple Risk Factor Intervention Trial. Multiple Risk Factor Intervention Trial Research Group. Arch Intern Med. 1992;152:1490-1500.
62. Kuntz KM, Fleischmann KE, Hunink MG, Douglas PS. Cost-effectiveness of diagnostic strategies for patients with chest pain. Ann Intern Med. 1999;130:709-718.
63. Garber AM, Solomon NA. Cost-effectiveness of alternative test strategies for the diagnosis of coronary artery disease. Ann Intern Med. 1999;130:719-728.
64. Shaw LJ, Hachamovitch R, Berman DS, et al. The economic consequences of available diagnostic and prognostic strategies for the evaluation of stable angina patients:an observational assessment of the value of precatheterization ischemia. Economics of Noninvasive Diagnosis (END) Multicenter Study Group. J Am Coll Cardiol. 1999;33:661-669.
65. Hunink MGM, Kuntz KM, Fleischmann KE, Brady TJ. Noninvasive imaging for the diagnosis of coronary artery disease:focusing the development of new diagnostic technology. Ann Intern Med. 1999;131:673-680.
66. Keavney B, Maider YA, McCance AJ, Skehan JD, Normal coronary angiograms: financial victory from the brink of clinical defeat. Heart. 1996;75:623-625.
67. Gotto JR AM, Boccuzzi SJ, Cook JR, et al. Effect of lovastatin on cardiovascular resource utilization and costs in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). Am J Cardiol. 2000;86:1176-1181.
68. Jacobson TA. "The lower the better" in hypercholesterolemia therapy:a reliable clinical guideline? Ann Intern Med. 2000;133:549-554.
69. Cohen DJ, Becker ER, Culler SD, et al. Impact of patient characteristics, complications, and facility volume on the costs and time of cardiac catheterization and coronary angioplasty in 70 catheterization laboratories. Am J Cardiol. 2000;86:595-601.
70. Anonymous. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 1994;344:1383-1389.
71. Gould KL. Coronary arteriography and lipid lowering: limitations, new concepts, and new paradigms in cardiovascular medicine. Am J Cardiol. 82:12M-21M.
72. Brown GB, Zhao XQ, Sacco DE, Albers JJ. Atherosclerosis regression, plaque disruption, and cardiovascular events:a rational for lipid lowering in coronary artery disease. Annu Rev Med. 1993;44:365-376.
73. Byrington RP, Jukema JW, Salonen JT, et al. Reduction in cardiovascular events during pravastatin therapy. Pooled analysis of clinical events of the Pravastatin Atherosclerosis Intervention Program. Circulation. 1995;92:2419-2425.
74. Herd JA, Ballantyne CM, Farmer JA, et al. Effects of fluvastatin on coronary atherosclerosis in patients with mild to moderate cholesterol elevations (Lipoprotein and Coronary Atherosclerosis Study [LCAS]). Am J Cardiol. 1997;80:278-286.
75. Sacks FM, Pfeffer MA, Moye LA, Rouleau JL, Rutherford JD, Cole TG. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. New Engl J Med. 1996;335:1001-1009.
76. Blumenthal RS, Cohn G, Schulman SP. Medical therapy versus coronary angioplasty in stable coronary artery disease:a critical review of the literature. J Am Coll Cardiol. 2000;36:668-673.